This invention relates to the field of
genetic engineering technology, and particularly to
TEV protease mutants, their preparation methods, and applications. This invention modifies the TEV
enzyme molecule, with
mutation points differing from those reported in previous studies. This enhances the activity of the
TEV protease at the
molecular level. Furthermore, this invention utilizes
CRISPR / Cas9
gene editing techniques to modify the host bacterial
chassis, obtaining engineered strains that express TEV at high yields. Further, the provided high-density
fermentation control method can rapidly promote TEV
enzyme expression, resulting in high E.
coli cell yield, with an OD600 value reaching approximately 150, a
cell wet weight of 80–130 g / L, and high expression levels of the
target protein, accounting for 40%–64% of the total
bacterial protein. Simultaneously, the method provided by this invention is simple and easy to implement, using readily available raw materials, achieving good application results while reducing production costs, resulting in significant
economic benefits.